Purdue's settlement has the support of all eligible US states States pledge to spend settlement funds to address the opioid addiction crisis Some individuals pressed for more details on how the funds ...

Purdue Pharma, the maker of OxyContin, has agreed to plead guilty to three federal criminal charges for its role in creating the nation’s opioid crisis and will pay more than $8 billion and ...

Purdue Pharma is being sued by almost every state and more than 2,500 other plaintiffs, most of them local governments spending billions to treat opioid abuse and respond to life-or-death 911 calls.

Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid claims even though they themselves were not declaring bankruptcy. In ...

A few years later, federal attorneys had enough evidence of misconduct to commence an investigation into Purdue Pharma’s advertising strategy, including print ads that overstated the benefits of ...

NEW YORK- Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to resolve thousands of opioid lawsuits against the drugmaker ...

Purdue Pharma’s owners from the Sackler family have struck a new $6.5 billion settlement of mass litigation alleging they fueled addiction, reopening a path to end the longest and costliest ...

All 50 US states have agreed to the OxyContin maker Purdue Pharma ‘s latest plan to settle thousands of lawsuits over the toll of opioids. A judge on Wednesday is being asked to clear the way ...

Purdue Pharma, the maker of OxyContin, won bankruptcy approval on Sept. 1, as part of a far-ranging settlement that ended thousands of lawsuits against the company and its owners, the Sacklers.

Purdue Pharma’s Sackler family owners are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits while accepting some exposure to future litigation.

The biggest difference between Purdue’s earlier proposals and this latest plan is a payment increase of $1.3 billion from the Sacklers and the addition of two more years (from seven to nine) to ...